Post by
bossu on Sep 15, 2022 11:33am
Another milestone to bring Opaens to a new level...
The global TAVR market is currently estimated at over 200,000 procedures and is expected to reach 400,000 in 2027.
The OptoWire has been used in the diagnosis and treatment of over 150,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan, and Canada.
Now they have the stamp approved by Health Autorities of 2 countries and soon by Europeen health autorities.
Market is wide open to Opsens and ''Marketing and Sales ''ready to take orders and sign agreement in a large market and soon to be global player.